期刊
ALLERGY
卷 64, 期 3, 页码 335-347出版社
WILEY
DOI: 10.1111/j.1398-9995.2009.01972.x
关键词
allergy; asthma; regulatory T-cell
资金
- European Union Thymaide programme
- Asthma-UK
- Medical Research Council [G0400503B] Funding Source: researchfish
The main focus of this review was the role of a specific subset of T cells with immunomodulatory or immunosuppressive activities, termed regulatory T cells (Tregs), in the pathogenesis and treatment of bronchial asthma. Evidence that these cells are important in maintaining immune homeostasis in health and exhibit impaired activity in active disease will be discussed. Their therapeutic potential is perhaps best highlighted by evidence that therapies with demonstrated efficacy in allergic and asthmatic disease are associated with the induction or restoration of regulatory T-cell function, e.g. glucocorticoids, allergen immunotherapy. Strategies to improve the safety and efficacy of these treatments and that induce or boost Tregs in bronchial asthma are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据